Skip to main content
Pharma Equity Group A/S logo

Pharma Equity Group A/S — Investor Relations & Filings

Ticker · BLVIS ISIN · DK0061155009 LEI · 2138008SUI4D917FKN20 CO Financial and insurance activities
Open in API
Filings indexed 1,627 across all filing types
Latest filing 2009-11-13 Transaction in Own Shar…
Country DK Denmark
Listing CO BLVIS

About Pharma Equity Group A/S

https://bcbsfepvision.com/

Pharma Equity Group A/S is an investment company specializing in early-stage biotechnology, life science, and MedTech companies. The group's mission is to support its portfolio companies in developing novel therapies and effective medicines for unmet medical needs. A primary investment is its subsidiary, Reponex Pharmaceuticals, a clinical-stage biopharmaceutical company focused on developing treatments for serious, acute, and chronic inflammatory diseases. The company is actively expanding its portfolio through strategic acquisitions to support its growth.

Recent filings

Filing Released Lang Actions
Transaction in Own Shares 2009
Transaction in Own Shares Classification · 99% confidence The document title explicitly mentions "§ 28 MEDDELELSE – EGNE AKTIER" which translates to a notification regarding 'Own Shares' or treasury shares. The text confirms that the company has disposed of its own shares and no longer holds any. This directly corresponds to the definition of a Transaction in Own Shares (share repurchase/issuance). The appropriate code is POS.
2009-11-13 English
Regulatory Filings 2009
Regulatory Filings
2009-11-13 Danish
M&A Activity 2009
M&A Activity Classification · 99% confidence The document details significant corporate actions, specifically the acquisition of a 70% stake in Strandpromenaden A/S, changes in ownership structure among major shareholders (Kiwi, Intrinsic, Norling Kierkegaard, Stranden, Blue Estate), and outlines a new corporate strategy focused on real estate investment. It also mentions upcoming general meetings for board elections and the need for major shareholder notifications ('Der vil blive udsendt behørige storaktionærmeddelelser i takt med transaktionernes gennemførelse'). The content strongly suggests a major corporate event announcement related to financing, M&A, and shareholder structure changes, rather than a routine periodic financial report (like 10-K or IR) or a simple dividend/earnings release. Since it involves a significant transaction (acquisition of a company and subsequent share transfers among existing large shareholders), it fits best under Capital/Financing Update (CAP) or potentially M&A Activity (TAR). Given the dual focus on acquiring a property asset and restructuring the shareholder base, 'CAP' (Capital/Financing Update) is a strong fit, as it covers fundraising and capital structure changes. However, the core of the announcement is the acquisition of a controlling stake in another entity, which aligns closely with M&A Activity (TAR). Since the document is a detailed announcement of a major transaction involving share purchases and options, TAR is the most precise fit for the acquisition aspect, although CAP is also relevant due to the financing elements mentioned (issuing own shares as consideration, securing loans). Given the detailed breakdown of the acquisition of 70% of shares and options for the remaining 30%, I classify this as M&A Activity (TAR).
2009-11-13 English
Regulatory Filings 2009
Regulatory Filings
2009-11-13 Danish
M&A Activity 2009
M&A Activity
2009-11-11 Danish
M&A Activity 2009
M&A Activity Classification · 98% confidence The document is titled 'Bestyrelsens redegørelse i henhold til § 14 i bekendtgørelse nr. 947 af 23. september 2008 om overtagelsestilbud' (Board's statement pursuant to § 14 of the Takeover Bid Regulation). It explicitly discusses a mandatory purchase offer ('pligtigt købstilbud') made by Kiwi Deposit Holdings A/S to the shareholders of Blue Vision A/S. This type of official board statement regarding a takeover bid or merger proposal directly corresponds to the definition of M&A Activity (TAR). Although it is a formal statement, it is the core document related to the transaction, not just an announcement of a report (RPA/RNS).
2009-11-11 English

Browse filings by year

20 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.